Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...

Beta blockers seem safe, even in the initial weeks of treatment. * THE QUESTION Do beta blocker drugs endanger patients' lives before producing beneficial effects? * PAST STUDIES have shown that ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...

An informal, nonsanctioned meta-analysis of 10 recent clinical trials in heart failure [1] has confirmed the importance of ALLHAT (the Antihypertensive and Lipid-Lowering treatment to prevent Heart ...

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...

Traditional beta-blockers target beta1-adrenergic receptors, which helps to prevent heart cells from dying and exacerbating a case of heart failure. However, beta1-adrenergic are also responsible for ...

LONDON (AP) -- A large head-to-head comparison of two widely used heart drugs known as beta blockers found one significantly superior in prolonging the lives of people with chronic heart failure. Some ...

Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained ...

The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...

β-blockers may increase depression risk in heart attack survivors with normal heart function, questioning their necessity for this group. The REDUCE-AMI trial found long-term β-blocker use linked to ...